Every month we provide our subscribers with some of the latest news about our projects and studies and how we are working to ensure that medicines and vaccines are made available for children in the right dose, formulation and at the right time.
Sign up to the Penta Newsletter to keep up to date with us!
Before proceeding, please read our Newsletter Privacy Notice.

July / August 2026: Simpler HIV treatment, shorter hospital stays
This month brings important progress for children’s health: new data supporting simplified HIV treatment; evidence that may help inform the management of severe pneumonia in hospitalised children; and new insights into how school-related measures affected COVID-19 transmission, that could help inform future responses to respiratory epidemics.
June 2026: Explore Penta’s 2025 Annual Report
Penta’s 2025 Annual Report is now available on our website! Last year brought significant milestones, even against a backdrop of growing antimicrobial resistance, funding uncertainty and persistent health inequities. Read the newsletter to find out more.
April 2026: Why CMV deserves more attention
Did you know? Cytomegalovirus (CMV) is far more common than many people realise. While usually harmless in healthy adults, it can have serious consequences for infants and children, particularly those living with HIV. Congenital CMV affects around 0.67% of births worldwide, with rates up to three times higher in low-resource settings. It is a major cause of hearing loss and neurodevelopmental disability, yet awareness and routine screening remain limited.